Samsung Life Science Fund Invests $10 Million in U.S. Alzheimer’s Blood Test Company
Samsung Life Science Fund is investing $10 million in a company developing technology for Alzheimer’s disease diagnostics. Samsung…
C2N Diagnostics
1 개의 기사가 있습니다.